BCR/ABL, a constitutively activated tyrosine kinase, activates several intracellular signaling pathways that promote the growth, proliferation, and survival of CML cells3. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.